Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as Immune Prognostic Biomarker in Breast Cancer Treated by Neo Adjuvant Chemotherapy
Clinical trial NCT01513408 · UNKNOWN
Trial details
- NCT number
- NCT01513408
- Sponsor
- Centre Georges Francois Leclerc
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2015-10-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.